Idiopathic pulmonary fibrosis (IPF) is generally defined as a progressive, fibrosing
inflammatory disease of the lung parenchyma of unknown cause. It is characterized by …

Idiopathic pulmonary fibrosis is a nonmalignant disease, yet it carries a prognosis akin to, or
even worse than, many cancers. Until recently, lung transplantation has been the only …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown cause characterized
by relentlessly progressive restrictive-ventilatory limitation, hypoxia, dyspnea, and cough …

Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis (CFA), is a
chronic scarring illness limited to the lung and characterized by progressive dyspnea …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and typically fatal interstitial
lung disease. Besides its grave natural history and prognosis, three aspects of IPF challenge …

Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease of the lung with unknown
etiology and limited treatment options. Once thought to be slowly progressive disease, more …

Pulmonary fibrosis is a component of over 200 interstitial lung diseases. Some have known
etiologies, however, for many diseases, the etiology remains unknown or obscure. This brief …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal form of diffuse interstitial
lung disease. Management of IPF requires an orderly approach, with regular evaluations …

Background Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial
disease of the lung and has the worst prognosis of all such diseases, with a median survival …

Objective Create a timeline of diagnosis and treatment for IPF in the US. Design, setting, and
participants A retrospective analysis was performed in collaboration with the OptumLabs …